ABSTRACT
INTRODUCTION
Dipeptidyl peptidase IV (DPPIV) is a multifunctional protein whose function depends upon the cell type, intracellular or 21 extracellular location, and the specific physiological and cellular conditions under which it is expressed [1] . It exhibits 22 proteolytic activity towards proteins that contain either alanine or proline next to the N-terminal position [2] . It is expressed 23 as a membrane protein with an extracellular domain, or a soluble serum protein with similar catalytic activity [3] . The 24 natural substrates for DPPIV are many, and include proteins such as glucose-like peptide 1 [4], natriuretic peptide [5] , and 25 the RANTES (Regulated on Normal T-cell Expressed and Secreted) protein [6] , which are involved in a broad spectrum of 26 biological activities such as glucose metabolism, diuresis, apoptosis, cell adhesion, and immune modulation [7] . Because 27 of its wide array of clinically-relevant functions, DPPIV has been the target of many inhibitors that are used as drugs [8] . It 28 is also used as a diagnostic/prognostic factor for various tumors, inflammatory disorders, and viral infections [8] . 29 30
The immunological activity of DPPIV stems from its proteolytic activities, and also from its interaction with chemokines [9] . 31
It is an important factor for T-cell growth and proliferation during the inflammatory response, and is a modulator of T-cell 32 chemotaxis [2] . The enzyme activity of DPPIV has also been associated with immune competency in vivo [10] . In 33 addition, decreased DPPIV activity has been identified in patients with immunodeficiency diseases, such as HIV- 
Treatment of Animals

51
Blood samples were collected from Komodo dragons at the Houston and San Antonio zoos. The amount of blood 52 collected from each individual depended on the size of the animal, and was at the discretion of the attending veterinarian 53 at each institution. Blood was collected from the tail caudal veins of three adults (20 -81.5 kg) and five juveniles (1.5 -6.2 54 kg), transferred to Vaccutainer™ tubes, and allowed to clot for at least five hr before serum was collected by 55 centrifugation. The serum was pooled so that the average DPPIV activities for this species could be generated [16] . 56 57
DPPIV assay
58
For the experiment in which the dependence of DPP4 activity on serum concentration was investigated, different volumes 59 of Komodo dragon serum were diluted to 750 µL with assay buffer (100 mM Tris-HCl, pH 7.4), and then incubated for 60 60 min with 10 µL of 1.0 mg/mL Ala-Pro-AFC. Stop buffer (750 µL, 100 mM Tris-HCl, pH 7.4, 15 mM EDTA) was added, the 61 samples were transferred to cuvettes and the fluorescent intensities were measured at an excitation λ of 395 nm (slit = 2 62 nm) and an emission λ of 530 nm (slit = 2 nm) in a Horiba Jobin Yvon Fluoromax™-4 fluorimeter. The presence of DPPIV 63 activity resulted in cleavage of AFC from the dipeptide, which produced large increases in fluorescent intensities under 64 these spectrofluorimetric conditions. 65 66
The effects of diprotin A on the hydrolysis of Ala-Pro-AFC were determined. Different amounts of diprotin A were added 67 to Komodo dragon serum preparations, followed by the addition of Ala-Pro-AFC substrate to a final concentration of 40 68 µM. Samples were incubated at ambient temperature for 1 h, and the fluorescent intensity was measured as described 69 above. 70 71
For the kinetic experiment, 2.0 mL of Komodo dragon serum were added to 27.7 mL of assay buffer. Upon the addition of 72 400 µL of 1.0 mg/mL Ala-Pro-AFC, samples were removed to 750 mL of stop buffer at different time points, and the 73 samples were transferred to cuvettes and the fluorescent intensities were measured as described above. 74 75
To examine the effects of temperature on enzyme activity, 10 µL of 1.0 mg/mL Ala-Pro-AFC was diluted to 750 mL with 76 assay buffer, incubated at different temperatures (5-40 o C, at 5 o C intervals) for 15 min, and then the reaction was started 77 by the addition of 10 mL of Komodo dragon serum. After 60 min, 750 mL of stop buffer was added, the samples were 78 transferred to cuvettes, and the fluorescent intensities were measured as described above. 79 80
Statistics and controls
81
The DPPIV activities are expressed as nmol of product formed and represent the mean ± standard deviations of four 82 independent determinations for each data point. The fluorescent intensities derived from each assay were compared to a 83 linear standard curve generated with AFC, and the mass of product formed was calculated using the linear regression 84 analysis of the data. The statistical comparisons between groups were conducted using analyses of variance (P < 0.5 as 85 significant) and Duncan's post-hoc comparisons. 86 87
RESULTS AND DISCUSSION
88
Incubation of different volumes of serum from Komodo dragons with the Ala-Pro-AFC substrate resulted in a near linear 89 increase in DPPIV activity from, 1-100 µL (Figure 1 ). Substantial production of fluorescent product (5.8 ± 0.8) was 90 observed with only one µL of serum. Increased volumes of 10, 20, 50, and 100 µL resulted in 26.7 ± 1.1, 47.7 ± 1.9, 91 100.2 ± 5.0, and 160.5 ± 3.6 nmol of product formed, respectively. were diluted with isotonic saline, and incubated with Ala-Pro-AFC for 15 min, and the DPPIV activity was measured as 97 described in the Materials and Methods. The data are expressed as nmol of product formed, and represent the means ± 98 standard deviations for four independent determinations. 99 100 101
The amount of product formed, using different volumes of Komodo dragon serum, is higher that observed for crocodilian 102 species when comparable volumes were used. By way of comparison, the maximum activity observed in this study was 103 160.5 ± 3.6 nmol of product formed (100 µL serum), while 
CONCLUSION
182
To date, the majority of work with DPPIV in reptiles has been focused on snake venoms [21] . However, a few studies 183 exist in which the soluble serum DPPIV have been characterized in crocodilians [16] [17] [18] 20] . Although these studies did 184 not link DPPIV activity to immune competency, it was assumed that these activities were immunologically important, due 185 to the presence in the peripheral circulation. 186 187 This is the first study to characterize DPPIV in any Varanid lizard. Although the results to not show a definitive link 188 between DPPIV activity and immune function, it is likely that this enzyme plays an important role in the regulation of both 189 innate and adaptive immune processes. It is critically important to understand the disease and immunity of wildlife 190 populations in order to understand susceptibilities to pathogenic colonization [13] [14] . The results from this study will add 191 to the growing body of knowledge concerning the immunological capabilities of these endangered reptiles. 192
